Gabapentin Capsule
Product Images NDC 50090-7388

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7388). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Equation (Equation)

Equation (Equation)
This text provides formulas for calculating creatinine clearance (CLCr) adjusted for age, weight, and gender for medical and pharmacological purposes. The formula involves multiplying age in years by weight in kilograms and dividing by the product of 72 and serum creatinine level in mg/dL, adjusted by a scaling factor of 0.85 for female patients.*
FDA Label Image

Fig 1 (Fig 1)

Fig 1 (Fig 1)
FDA Label Image

Fig 2 (Fig 2)

Fig 2 (Fig 2)
FDA Label Image

Fig 3 (Fig 3)

Fig 3 (Fig 3)
FDA Label Image

Fig 4 (Fig 4)

Fig 4 (Fig 4)
This text describes Figure 4 showing the responder rate in patients receiving Gabapentin, expressed as a difference from placebo by dose and study. The study included adjunctive therapy studies in patients over 12 years of age with partial seizures. The table includes dosages of 120 and 1800 mg daily dose.*
FDA Label Image

Structure (Struct)

Structure (Struct)
FDA Label Image

Label Image (Lbl500907388)

Label Image (Lbl500907388)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.